Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptid
SSX2IP
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle SSX2IP Produkte
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SSX2IP antibody (Catalog #: ARP53690_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Hintergrund
-
SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
Alias Symbols: ADIP, FLJ10848, KIAA0923, MGC75026
Protein Interaction Partner: ACTN1,ACTN2,MLLT4,SSX2,SSX2IP,SSX3,ACTN1,MLLT4,USP11
Protein Size: 614 - Molekulargewicht
- 68 kDa
- Gen-ID
- 117178
- NCBI Accession
- NM_014021, NP_054740
- UniProt
- Q9Y2D8
-
Sie sind hier:
